1966
DOI: 10.1016/s0040-4039(01)82822-7
|View full text |Cite
|
Sign up to set email alerts
|

Zur kenntnis der rubromycine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 47 publications
(23 citation statements)
references
References 7 publications
0
23
0
Order By: Relevance
“…The evaluation of the 13 C-NMR spectrum indicated that [1,[3][4][5][6][7][8][9][10][11][12][13] C 2 ]acetoacetic acid was not incorporated into 6. Currently, this negative result does not allow to differentiate between the mentioned alternatives.…”
Section: Biosynthesismentioning
confidence: 99%
“…The evaluation of the 13 C-NMR spectrum indicated that [1,[3][4][5][6][7][8][9][10][11][12][13] C 2 ]acetoacetic acid was not incorporated into 6. Currently, this negative result does not allow to differentiate between the mentioned alternatives.…”
Section: Biosynthesismentioning
confidence: 99%
“…g-Rubromycin [1] (1, Scheme 1), the prototypical member of a structurally related family of antibiotics known as the rubromycins, consists of a densely oxygenated naphthazarin ring and an isocoumarin moiety linked through a unique aromatic 5,6-spiroketal ring system (Scheme 1). The rubromycins exhibit a wide range of biological activity including antimicrobial and anticancer properties.…”
mentioning
confidence: 99%
“…[15] 4-Substituted chroman-2-ol 5 is a synthetically valuable intermediate that can be easily converted into chromans and their derivatives with antimicrobial and anticancer properties. [16] Good to excellent yields (up to 96 %) were achieved for products 3c-f, 3h-i, 3m, and 5 ( Table 1). The lower yields of 3j-l (31-37 %) were caused by the low conversion rates with nitrostyrene derivatives 2j-l and the non-enzymatic hydration of 2j-l in aqueous reaction media.…”
Section: Resultsmentioning
confidence: 90%